{"transactions":[{"id":830846,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-23T16:30:16.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":59073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to the option shall vest March 1, 2027,  and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":59073,"derivative":{"exercise_price":16.82,"expiration_date":"2036-03-18","underlying":"Ordinary Shares","underlying_shares":59073},"source":{"system":"sec-edgar","filing":"0001801842-26-000003","document":"form4-03232026_040310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000180184226000003/form4-03232026_040310.xml","form_type":"4"}},{"id":830845,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-23T16:30:16.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":47706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one ordinary share of the Issuer.  The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates."}],"balance_after":155187,"source":{"system":"sec-edgar","filing":"0001801842-26-000003","document":"form4-03232026_040310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000180184226000003/form4-03232026_040310.xml","form_type":"4"}},{"id":858679,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"American Depositary Shares","published_at":"2026-03-05T18:20:07.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Voluntary reporting of the acquisition of 237 ADSs by the Reporting Person on November 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":462,"derivative":{"underlying":"Ordinary Shares","underlying_shares":711},"source":{"system":"sec-edgar","filing":"0001801842-26-000002","document":"form4-03052026_060304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000180184226000002/form4-03052026_060304.xml","form_type":"4"}},{"id":858678,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"American Depositary Shares","published_at":"2026-03-05T18:20:07.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Voluntary reporting of the acquisition of 225 ADSs by the Reporting Person on May 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":225,"derivative":{"underlying":"Ordinary Shares","underlying_shares":675},"source":{"system":"sec-edgar","filing":"0001801842-26-000002","document":"form4-03052026_060304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000180184226000002/form4-03052026_060304.xml","form_type":"4"}},{"id":858677,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T18:20:07.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4836,"price":20.99,"value":101507.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":107481,"source":{"system":"sec-edgar","filing":"0001801842-26-000002","document":"form4-03052026_060304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000180184226000002/form4-03052026_060304.xml","form_type":"4"}},{"id":1034646,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2025-09-22T21:25:06.000Z","date":"2025-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":6021,"price":7.7433,"value":46622.4093,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":112317,"source":{"system":"sec-edgar","filing":"0001801842-25-000004","document":"form4-09222025_090903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000180184225000004/form4-09222025_090903.xml","form_type":"4"}},{"id":1200086,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-18T20:45:14.000Z","date":"2025-03-15","kind":"grant","planned":false,"acquired":true,"shares":124032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to the option shall vest March 1, 2026,  and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":124032,"derivative":{"exercise_price":7.02,"expiration_date":"2035-03-15","underlying":"Ordinary Shares","underlying_shares":124032},"source":{"system":"sec-edgar","filing":"0001415889-25-008554","document":"form4-03182025_080311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000141588925008554/form4-03182025_080311.xml","form_type":"4"}},{"id":1200085,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-18T20:45:14.000Z","date":"2025-03-15","kind":"grant","planned":false,"acquired":true,"shares":51048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one ordinary share of the Issuer.  The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates."}],"balance_after":118338,"source":{"system":"sec-edgar","filing":"0001415889-25-008554","document":"form4-03182025_080311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000141588925008554/form4-03182025_080311.xml","form_type":"4"}},{"id":1401665,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Share option (right to buy)","published_at":"2024-09-20T17:47:35.000Z","date":"2024-09-18","kind":"grant","planned":false,"acquired":true,"shares":82890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth of the shares vest on the first anniversary of September 18, 2024, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":82890,"derivative":{"exercise_price":12.75,"expiration_date":"2034-09-17","underlying":"Ordinary Shares","underlying_shares":82890},"source":{"system":"sec-edgar","filing":"0001415889-24-023794","document":"form4-09202024_090932.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000141588924023794/form4-09202024_090932.xml","form_type":"4"}},{"id":1401664,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2024-09-20T17:47:35.000Z","date":"2024-09-18","kind":"grant","planned":false,"acquired":true,"shares":67290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock unit award granted under the Issuer's 2023 Equity Incentive Plan."}],"balance_after":67290,"source":{"system":"sec-edgar","filing":"0001415889-24-023794","document":"form4-09202024_090932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000141588924023794/form4-09202024_090932.xml","form_type":"4"}},{"id":1794314,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-08-29T17:04:03.000Z","date":"2023-08-28","kind":"exercise","planned":false,"acquired":false,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest in a series of 16 equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date."}],"balance_after":109375,"derivative":{"exercise_price":1.8,"expiration_date":"2032-12-08","underlying":"Common Stock","underlying_shares":15625},"source":{"system":"sec-edgar","filing":"0001209191-23-047626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000120919123047626/doc4.xml","form_type":"4"}},{"id":1794313,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-08-29T17:04:03.000Z","date":"2023-08-28","kind":"sale","planned":false,"acquired":false,"shares":15625,"price":6.2757,"value":98057.8125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.24 to $6.44, inclusive. The reporting person undertakes to provide any security holder of Reneo Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":39600,"source":{"system":"sec-edgar","filing":"0001209191-23-047626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000120919123047626/doc4.xml","form_type":"4"}},{"id":1794312,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-08-29T17:04:03.000Z","date":"2023-08-28","kind":"exercise","planned":false,"acquired":true,"shares":15625,"price":1.8,"value":28125.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,000 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the \"Plan\") on June 8, 2023."}],"balance_after":55225,"source":{"system":"sec-edgar","filing":"0001209191-23-047626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000120919123047626/doc4.xml","form_type":"4"}},{"id":2088101,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-12-13T18:11:48.000Z","date":"2022-12-09","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest in a series of 16 equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date."}],"balance_after":125000,"derivative":{"exercise_price":1.8,"expiration_date":"2032-12-08","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-061038","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000120919122061038/doc4.xml","form_type":"4"}},{"id":2512935,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-15T19:49:17.000Z","date":"2021-11-12","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vest and become exercisable on October 11, 2022, and the remaining shares vest in equal monthly installments over the subsequent 36 months."}],"balance_after":180000,"derivative":{"exercise_price":8.85,"expiration_date":"2031-11-11","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001209191-21-064587","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000120919121064587/doc4.xml","form_type":"4"}},{"id":2512934,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-11-15T19:49:17.000Z","date":"2021-11-12","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001209191-21-064587","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000120919121064587/doc4.xml","form_type":"4"}},{"id":2890508,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-29T17:01:05.000Z","date":"2021-01-28","kind":"grant","acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a four (4) year period in equal quarterly installments, the first of which will be May 15, 2021."}],"balance_after":31000,"derivative":{"exercise_price":32.12,"expiration_date":"2031-01-28","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001628280-21-001177","document":"wf-form4_161195765095069.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000162828021001177/wf-form4_161195765095069.xml","form_type":"4"}},{"id":2890507,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-01-29T17:01:05.000Z","date":"2021-01-28","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The options vest over a four (4) year period in equal quarterly installments, the first of which will be May 15, 2021."}],"balance_after":22500,"source":{"system":"sec-edgar","filing":"0001628280-21-001177","document":"wf-form4_161195765095069.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000162828021001177/wf-form4_161195765095069.xml","form_type":"4"}}]}